These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 10776081)

  • 21. Efficacy and tolerability of intravenous ferric gluconate in the treatment of iron deficiency anemia in patients without kidney disease.
    Miller HJ; Hu J; Valentine JK; Gable PS
    Arch Intern Med; 2007 Jun; 167(12):1327-8. PubMed ID: 17592108
    [No Abstract]   [Full Text] [Related]  

  • 22. Chronic kidney disease: Serious adverse effects associated with IV iron in CKD.
    Allison SJ
    Nat Rev Nephrol; 2015 Sep; 11(9):506. PubMed ID: 26149838
    [No Abstract]   [Full Text] [Related]  

  • 23. Maintaining iron balance with total-dose infusion of intravenous iron dextran.
    Case G
    ANNA J; 1998 Feb; 25(1):65-8. PubMed ID: 9543911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical perspective: iron replacement therapy in chronic heart failure.
    Cowie MR; Lucas R
    Int J Clin Pract; 2011 Jun; 65(6):645-8. PubMed ID: 21564435
    [No Abstract]   [Full Text] [Related]  

  • 25. FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease.
    Lu M; Cohen MH; Rieves D; Pazdur R
    Am J Hematol; 2010 May; 85(5):315-9. PubMed ID: 20201089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of outpatient treatment with intravenous iron in selected primary Care patients.
    Rivilla Marugán L; Lorente Aznar T; García-Erce JA
    Med Clin (Barc); 2020 Jan; 154(2):66-67. PubMed ID: 30497767
    [No Abstract]   [Full Text] [Related]  

  • 27. [Parenteral iron therapy: problems and possible solutions].
    Hoigné R; Breymann C; Künzi UP; Brunner F
    Schweiz Med Wochenschr; 1998 Apr; 128(14):528-35. PubMed ID: 9592894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sodium ferric gluconate complex therapy in anemic children on hemodialysis.
    Warady BA; Zobrist RH; Wu J; Finan E;
    Pediatr Nephrol; 2005 Sep; 20(9):1320-7. PubMed ID: 15971073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison between intravenous iron polymaltose complex (Ferrum Hausmann) and oral ferrous fumarate in the treatment of iron deficiency anaemia in pregnancy.
    Singh K; Fong YF; Kuperan P
    Eur J Haematol; 1998 Feb; 60(2):119-24. PubMed ID: 9508353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease.
    Sinha S; Chiu DY; Peebles G; Kolakkat S; Lamerton E; Fenwick S; Kalra PA
    J Ren Care; 2009 Jun; 35(2):67-73. PubMed ID: 19432851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.
    Van Wyck DB; Mangione A; Morrison J; Hadley PE; Jehle JA; Goodnough LT
    Transfusion; 2009 Dec; 49(12):2719-28. PubMed ID: 19682342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron hydroxide polymaltose: iatrogenic cause of persistent iron deficiency anaemia despite continuous oral iron therapy.
    Mehta BC
    J Assoc Physicians India; 2002 Feb; 50():279-80. PubMed ID: 12038667
    [No Abstract]   [Full Text] [Related]  

  • 33. Should intravenous iron be upfront therapy for iron deficiency anemia?
    Auerbach M
    Pediatr Blood Cancer; 2011 Apr; 56(4):511-2. PubMed ID: 21298731
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial.
    Garrido-Martín P; Nassar-Mansur MI; de la Llana-Ducrós R; Virgos-Aller TM; Rodríguez Fortunez PM; Ávalos-Pinto R; Jimenez-Sosa A; Martínez-Sanz R
    Interact Cardiovasc Thorac Surg; 2012 Dec; 15(6):1013-8. PubMed ID: 22940889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. eComment. The problem of anaemia correction in cardiac surgery patients.
    Bockeria LA; Bockeria O; Sokolskaya M; Donakanian S
    Interact Cardiovasc Thorac Surg; 2012 Dec; 15(6):1018; discussion 1018. PubMed ID: 23166216
    [No Abstract]   [Full Text] [Related]  

  • 36. A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy.
    Khalafallah A; Dennis A; Bates J; Bates G; Robertson IK; Smith L; Ball MJ; Seaton D; Brain T; Rasko JE
    J Intern Med; 2010 Sep; 268(3):286-95. PubMed ID: 20546462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous iron therapy in heart failure: a different perspective.
    Ghafourian K; Chang HC; Ardehali H
    Eur J Heart Fail; 2019 Jun; 21(6):703-714. PubMed ID: 30884037
    [No Abstract]   [Full Text] [Related]  

  • 38. Evolution of iv iron compounds over the last century.
    Macdougall IC
    J Ren Care; 2009 Dec; 35 Suppl 2():8-13. PubMed ID: 19891680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous Iron Use in the Care of Patients with Kidney Disease.
    Macdougall IC
    Clin J Am Soc Nephrol; 2019 Oct; 14(10):1528-1530. PubMed ID: 31175103
    [No Abstract]   [Full Text] [Related]  

  • 40. Anemia management in chronic kidney disease: intravenous iron steps forward.
    Coyne DW; Auerbach M
    Am J Hematol; 2010 May; 85(5):311-2. PubMed ID: 20232350
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.